Remodelling of the Bone Microenvironment During Cancer Infiltration: Insights from Multiplex Imaging and Spatial Transcriptomics
Bone is a dynamic tissue shaped by continuous interactions among osteoclasts, osteoblasts, stromal cells, immune populations, and the surrounding extracellular matrix. When cancer cells infiltrate bone, this finely balanced microenvironment undergoes extensive structural and molecular remodelling that supports metastatic growth.
This presentation uses principles of normal bone remodelling as a foundation for understanding how tumor cells reshape the bone niche during metastasis. Drawing on patient‑derived samples primarily from breast and prostate cancer, the talk showcases multiplex imaging and spatial transcriptomics data that map interactions between cancer cells, fibroblasts, vasculature, nerves, and other key components of the metastatic microenvironment.
The session will also include practical guidance on pre‑analytical tissue handling to ensure high‑quality samples for spatial transcriptomics. Together, these insights highlight how spatially resolved technologies can deepen our understanding of bone metastasis biology in cancer.
Bone is a dynamic tissue shaped by continuous interactions among osteoclasts, osteoblasts, stromal cells, immune populations, and the surrounding extracellular matrix. When cancer cells infiltrate bone, this finely balanced microenvironment undergoes extensive structural and molecular remodelling that supports metastatic growth.
Show more
This presentation uses principles of normal bone remodelling as a foundation for understanding how tumor cells reshape the bone niche during metastasis. Drawing on patient‑derived samples primarily from breast and prostate cancer, the talk showcases multiplex imaging and spatial transcriptomics data that map interactions between cancer cells, fibroblasts, vasculature, nerves, and other key components of the metastatic microenvironment.
The session will also include practical guidance on pre‑analytical tissue handling to ensure high‑quality samples for spatial transcriptomics. Together, these insights highlight how spatially resolved technologies can deepen our understanding of bone metastasis biology in cancer.
Christina Møller Andreasen
Dr. Moeller Andreasen is an Associate Professor, PhD, at the Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, where she leads the Bone & Cancer Research team investigating bone metastases in breast and prostate cancer. Her research focuses on the cellular and molecular dynamics of the bone microenvironment during metastatic progression, with particular emphasis on how tumor – stroma interactions shape metastatic colonization, dormancy, and therapeutic resistance.
Dr. Moeller Andreasen is an Associate Professor, PhD, at the Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, where she leads the Bone & Cancer Research team investigating bone metastases in breast and prostate cancer. Her research focuses on the cellular and molecular dynamics of the bone microenvironment during metastatic progression, with particular emphasis on how tumor – stroma interactions shape metastatic colonization, dormancy, and therapeutic resistance.
She is a current member of the Academy of the European Calcified Tissue Society, actively contributing to bone research and mentoring within the European scientific community.
Dr. Moeller Andreasen is an Associate Professor, PhD, at the Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, where she leads the Bone & Cancer Research team investigating bone metastases in breast and prostate cancer. Her research focuses on the cellular and molecular dynamics of the bone microenvironment during metastatic progression, with particular emphasis on how tumor – stroma interactions shape metastatic colonization, dormancy, and therapeutic resistance.
Show more
Dr. Moeller Andreasen is an Associate Professor, PhD, at the Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, where she leads the Bone & Cancer Research team investigating bone metastases in breast and prostate cancer. Her research focuses on the cellular and molecular dynamics of the bone microenvironment during metastatic progression, with particular emphasis on how tumor – stroma interactions shape metastatic colonization, dormancy, and therapeutic resistance.
She is a current member of the Academy of the European Calcified Tissue Society, actively contributing to bone research and mentoring within the European scientific community.
Read the Abstracts from Our Invited Speakers
Cancer Biology
- AllergoOncology: Lessons Learned from the Allergy-Glioblastoma Connection
Aurélie Poli, Luxembourg Institute of Health, LUXEMBOURG
- Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
Joanna Poźniak, KU Leuven, BELGIUM
- Inducing Immunogenic Tertiary Lymphoid Structures Across Cancer Types With Dendritic Cell Reprogramming
Camille Chatelain, Lund University, SWEDEN
- The Role of ILC2 in Tissue Homeostasis and Neoplasia
Tim Halim, Cancer Research UK Cambridge Institute, UNITED KINGDOM
Cancer Neuroscience
- Latent Neuropathy in Colorectal Cancer: Implications for Cancer Survivorship
Andrew Shepherd, University of Texas MD Anderson Cancer Center, USA
- Remodelling of the Bone Microenvironment During Cancer Infiltration: Insights from Multiplex Imaging and Spatial Transcriptomics
Christina Møller Andreasen, University of Southern Denmark, DENMARK
- Enteric Nervous System-Derived VIP Restrains Differentiation of LGR5+ Stem Cells Towards the Secretory Lineage Impeding Type 2 Immune Programs
Christoph Klose, Charité – Berlin University Medicine, GERMANY
Cancer Therapy
- Targeting the Dark Matter of Cancer with AI-Designed Mini Binder
Tobias Bald, University of Bonn, DEUTSCHLAND
- Engineering Nanomedicines for Targeted Neuroimmune Modulation
Helena Florindo, University of Lisbon, PORTUGAL
- Potentiating Immunotherapy of Urological Cancers with Oncolytic Viruses
Gabriel van der Pluijm
- Cancer Neuroscience of Brain Tumors: From Basic Discoveries to Clinical TrialsKEYNOTE SPEAKER
Frank Winkler, Universitätsklinik Heidelberg, DEUTSCHLAND
- TBC
Sheeba Irshad, King’s College London, UNITED KINGDOM
- The War Against Glioblastoma Needs More Than Standard of Care
Stefaan Van Gool, IOZK Immun-Onkologisches Zentrum Köln, DEUTSCHLAND
- Uncovering the Spatial Regulation of γδ T Cells: Toward Receptor-Guided Immunotherapy
Jürgen Kuball, University Medical Center Utrecht, NETHERLANDS
- TBC
Jarosław Dybko, Lower Silesian Oncology Center in Wroclaw, POLAND
- Expanding CAR Targets to Non Protein Antigens
Sébastien Wälchli, Oslo University Hospital, NORWAY
- TBC
Helen Kakkassery, King’s College London, UNITED KINGDOM